| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 11. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | somatropin (Omnitrope®) |
| Formulation | 5 mg/1.5 ml, 10 mg/1.5 ml and 15 mg/1.5 ml solution for injection |
| Reference number | 614 |
| Indication | Replacement therapy in adults with pronounced growth hormone deficiency |
| Company | Sandoz Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 28/04/2016 |